Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma
Clinical trial NCT05240404 · UNKNOWN
Trial details
- NCT number
- NCT05240404
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2023-07-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.